Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China flag China · Delayed Price · Currency is CNY
12.32
-0.11 (-0.88%)
Sep 10, 2026, 1:45 PM CST

SHE:002275 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
693.61990.991,0501,0581,2661,478
Short-Term Investments
---43.4--
Trading Asset Securities
704.07730.31626.15304.69161.24221.77
Cash & Short-Term Investments
1,3981,7211,6761,4061,4271,699
Cash Growth
-15.78%2.72%19.17%-1.45%-16.03%-2.47%
Accounts Receivable
319.38290.05527.3458.33542.51413.03
Other Receivables
95.6198.43118.064.3957.589.1
Receivables
414.99388.47645.36462.72600.09422.13
Inventory
234.92203.26208.29255.96244.9284.15
Other Current Assets
82.6250.8735.1871.1725.0648.4
Total Current Assets
2,1302,3642,5652,1962,2972,454
Property, Plant & Equipment
1,1011,1091,1111,1551,2271,313
Long-Term Investments
574.7532.94296.89299.09132.614.21
Goodwill
5.75.75.75.75.75.7
Other Intangible Assets
131.46134.81141.55153.56168.28178.36
Long-Term Deferred Tax Assets
6.687.1210.29.338.5311.35
Long-Term Deferred Charges
92.8296.16102.44117.04125.76128.8
Other Long-Term Assets
-8.35---0.03
Total Assets
4,0424,2584,2323,9363,9654,096

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
186.7185.76191.55201.38133.92180.24
Accrued Expenses
60.15149.66184.85160.61160.45123.86
Short-Term Debt
5260.22325.26274.2140.01251.68
Current Portion of Long-Term Debt
35.935.17103.3104.54107.5733.04
Current Portion of Leases
10.4510.8914.7214.7211.819.52
Current Income Taxes Payable
24.7912.5138.6325.9571.7938.13
Current Unearned Revenue
16.5698.2298.0675.99170.01132.79
Other Current Liabilities
93.2731.9539.1136.4551.3859.98
Total Current Liabilities
432.82784.39995.46893.83846.94829.23
Long-Term Debt
226.57180.91121.573.92128.03226.93
Long-Term Leases
24.2926.5928.8660.9578.4587.93
Long-Term Unearned Revenue
89.5470.2363.1589.0497.85111.22
Long-Term Deferred Tax Liabilities
000.15-0.330.73
Other Long-Term Liabilities
5.055.0513.321.34--
Total Liabilities
778.271,0671,2221,1191,1521,256

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
587.57587.57587.57587.57587.57590.2
Additional Paid-In Capital
672.09672.09672.09669.24638.76685.78
Retained Earnings
2,0121,8951,7811,5831,5731,767
Treasury Stock
------204
Comprehensive Income & Other
-7.2836.78-31.12-22.7214.130.64
Shareholders' Equity
3,2643,1913,0102,8172,8132,840
Total Liabilities & Equity
4,0424,2584,2323,9363,9654,096

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
302.21513.78593.63528.33465.88609.1
Net Cash (Debt)
1,0951,2081,082877.86961.071,090
Net Cash Growth
7.78%11.59%23.27%-8.66%-11.86%-18.50%
Net Cash Per Share
1.862.061.851.501.631.90
Filing Date Shares Outstanding
587.57587.57587.57587.57587.57575.27
Total Common Shares Outstanding
587.57587.57587.57587.57587.57575.27
Working Capital
1,6971,5801,5691,3021,4501,625
Book Value Per Share
5.565.435.124.794.794.94
Tangible Book Value
3,1273,0512,8632,6582,6392,656
Tangible Book Value Per Share
5.325.194.874.524.494.62
Buildings
1,0761,0621,000993.15997.121,053
Machinery
805.63799.56773.59775.0676.8676.54
Construction In Progress
67.9854.6969.5421.2461.66105.26